Princeton Global Asset Management LLC - G1 THERAPEUTICS INC ownership

G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 115 filers reported holding G1 THERAPEUTICS INC in Q3 2021. The put-call ratio across all filers is 1.16 and the average weighting 0.0%.

Quarter-by-quarter ownership
Princeton Global Asset Management LLC ownership history of G1 THERAPEUTICS INC
ValueSharesWeighting
Q1 2022$11,000
-26.7%
1,5000.0%0.00%
-25.0%
Q4 2021$15,000
-25.0%
1,5000.0%0.00%
-33.3%
Q3 2021$20,000
-39.4%
1,5000.0%0.01%
-40.0%
Q2 2021$33,000
-8.3%
1,5000.0%0.01%
-16.7%
Q1 2021$36,000
+300.0%
1,500
+200.0%
0.01%
+300.0%
Q4 2020$9,0005000.00%
Other shareholders
G1 THERAPEUTICS INC shareholders Q3 2021
NameSharesValueWeighting ↓
MPM BioImpact LLC 650,000$3,529,5000.92%
CHI Advisors LLC 333,945$1,813,3210.48%
PVG ASSET MANAGEMENT CORP 15,585$84,6260.37%
Rhenman & Partners Asset Management AB 370,000$2,009,1000.21%
NEEDHAM INVESTMENT MANAGEMENT LLC 184,000$999,1200.18%
Birchview Capital, LP 40,000$2170.15%
XTX Topco Ltd 102,282$555,3910.12%
Tekla Capital Management LLC 423,869$2,301,6090.09%
Woodline Partners LP 1,028,967$5,587,2910.08%
Curi Wealth Management, LLC 81,009$439,8790.06%
View complete list of G1 THERAPEUTICS INC shareholders